Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (C...

Full description

Bibliographic Details
Main Author: Perpétuo, Inês Pedro (author)
Other Authors: Caetano-Lopes, joana (author), Rodrigues, Ana Maria (author), Campanilho-marques, Raquel (author), Ponte, Cristina (author), Canhao, Helena (author), Ainola, Mari-Mia (author), Fonseca, João Eurico (author)
Format: article
Language:eng
Published: 2021
Subjects:
Bone
DMARD
Monocytes
Osteoclast
Rheumatoid arthritis
Online Access:http://hdl.handle.net/10451/50213
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/50213
Description
Summary:© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Similar Items